Shanghai Henlius Biotech, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003N76
HKD
64.80
0.1 (0.15%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'23
Sep'23
Jun'19
Mar'19
Mar'18
Net Sales
1,585.95
1,541.06
18.51
1.07
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,585.95
1,541.06
18.51
1.07
0.00
Raw Material Cost
375.75
439.30
28.31
0.00
11.72
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
77.86
73.65
31.44
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
30.26
30.73
14.29
10.42
23.70
Selling and Distribution Expenses
706.67
612.46
57.95
21.54
15.53
Other Expenses
29.53
26.05
3.61
2.03
-0.33
Total Expenditure (Excl Depreciation)
1,407.94
1,343.02
214.55
125.89
79.13
Operating Profit (PBDIT) excl Other Income
178
198
-196
-124.80000000000001
-79.1
Other Income
22.87
13.87
34.87
-34.05
22.66
Operating Profit (PBDIT)
325.92
299.45
-139.66
-158.87
-44.75
Interest
30.26
30.73
14.29
10.42
23.70
Exceptional Items
0.00
0.00
-6.99
0.00
0.00
Gross Profit (PBDT)
1,210.20
1,101.77
-9.80
0.00
-11.72
Depreciation
125.05
87.54
21.50
14.63
11.72
Profit Before Tax
170.61
181.19
-182.45
-183.92
-80.17
Tax
21.19
0.00
0.00
0.00
3.34
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
149.42
181.19
-182.45
-183.92
-74.48
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
149.42
181.19
-182.45
-183.92
-74.48
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
-9.03
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
149.42
181.19
-182.45
-183.92
-83.51
Equity Capital
0.00
0.00
0.00
0.00
0.00
Face Value
1.1
1.07
1.14
1.17
1.25
Reserves
2,413.74
2,202.52
1,759.66
1,956.39
0.00
Earnings per share (EPS)
0.27
0.33
-0.35
-0.35
-0.14
Diluted Earnings per share
0.27
0.33
-0.35
-0.35
-0.14
Operating Profit Margin (Excl OI)
11.22%
12.85%
-1058.87%
-12975.11%
0.0%
Gross Profit Margin
18.64%
17.44%
-869.31%
-15751.19%
0.0%
PAT Margin
9.42%
11.76%
-985.46%
-17112.88%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Markets Mojo
Analysis not available
Compare Quarterly Results Of Shanghai Henlius Biotech, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
1,585.95
22.61
1,563.34
6,914.37%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,585.95
22.61
1,563.34
6,914.37%
Raw Material Cost
375.75
37.72
338.03
896.16%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
47.01
-47.01
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
30.26
4.28
25.98
607.01%
Selling and Distribution Expenses
706.67
21.14
685.53
3,242.81%
Other Expenses
29.53
8.08
21.45
265.47%
Total Expenditure (Excl Depreciation)
1,407.94
190.90
1,217.04
637.53%
Operating Profit (PBDIT) excl Other Income
178.00
-168.29
346.29
205.77%
Other Income
22.87
-14.28
37.15
260.15%
Operating Profit (PBDIT)
325.92
-161.99
487.91
301.20%
Interest
30.26
4.28
25.98
607.01%
Exceptional Items
0.00
-925.44
925.44
100.00%
Gross Profit (PBDT)
1,210.20
-15.11
1,225.31
8,109.27%
Depreciation
125.05
20.58
104.47
507.63%
Profit Before Tax
170.61
-1,112.29
1,282.90
115.34%
Tax
21.19
-0.03
21.22
70,733.33%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
149.42
-1,112.16
1,261.58
113.44%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
149.42
-1,112.16
1,261.58
113.44%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
149.42
-1,112.16
1,261.58
113.44%
Equity Capital
0
0
0.00
Face Value
1.10
0.00
0.00
Reserves
2,413.74
-2,168.47
4,582.21
211.31%
Earnings per share (EPS)
0.27
-2.56
2.83
110.55%
Diluted Earnings per share
0.27
-2.56
2.83
110.55%
Operating Profit Margin (Excl OI)
11.22%
-744.33%
0.00
755.55%
Gross Profit Margin
18.64%
-4,828.47%
0.00
4,847.11%
PAT Margin
9.42%
-4,918.90%
0.00
4,928.32%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales NA Million
in

Figures in Million
stock-summary

stock-summary

Quarterly - Standalone Net Profit
Standalone Net Profit NA Million
in

Figures in Million
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) NA Million
in

Figures in Million
Quarterly - Interest
Interest NA Million
in

Figures in Million
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) NA%
in

Figures in %